Museum of Science, Boston Announces 2022 Appointments to its Board of Trustees

September 13, 2022

Nine Trustees and 17 Advisors Join the Museum of Science Board to Further the Museum’s Mission

BOSTON, MA — The Museum of Science, Boston announced today the appointment of nine new Trustees and 17 Advisors to its Board. The Museum’s nominating committee proposed these appointments, which were approved unanimously by the Board on June 13, 2022.

The Museum’s Trustees and Advisors ensure that the Museum has the resources, leadership, and strategies necessary to fulfill its mission – inspiring a lifelong love of science in everyone, and vision -- a world where science belongs to each of us for the good of all of us. A full list of appointees can be found below.

“Each new class of Trustees and Advisors forms the next link in a chain of leadership that goes back to 1830. They, like the ones who have served before, help the Museum stay relevant to the world we live in,” said Board of Trustees Chair, Alexis Borisy, founder and executive chairman of EQRx. “As the Museum of Science responds to the needs of the communities we serve, our Trustees and Advisors play a vital role in helping the Museum listen to and understand those communities.”

The Museum of Science’s Trustees and Advisors represent a broad cross-section of Boston’s science-rich community. Composed of leaders from academia, industry and the general public, the Trustees and Advisors are united in their commitment to public science learning.

“Our Trustees and Advisors are the Museum’s ambassadors in a world that counts on it to give people a vision for a joyful, humane, and sustainable world. They love science, and want the same thing for others,” said Tim Ritchie, President of the Museum of Science. “We are grateful for their commitment, knowledge and skills.”

The Trustees lead the Museum in tandem with a wider group of Museum Advisors who are industry and community leaders with a special interest in science, technology, and education and who support the mission of the institution. The 17 new Museum Advisors also appointed at the annual meeting are listed below.

2022 Museum of Science Advisors Appointees:

Gaurdia Banister, Yvonne L. Munn Center for Nursing Research at Massachusetts General Hospital
Michael Belliveau, Clark+Elbing, LLP
Maria Berkman, Broadview Ventures
Anu Chitrapu, Bank of America
Joshua Devore, Amazon Web Services
Paige Fetzer-Borelli, Algorand
Ben Hall, McKinsey Academy
Kate Haviland, Blueprint Medicines
Mary Lynne Hedley, Broad Institute
Jarasa Kanok, Union of Concerned Scientists
Kristin Keating, RSM
Ben Leiden, Rapid7
Lawrence Neeley, Olin College of Engineering
Sukanya Lahiri Soderland, Blue Cross Blue Shield of Massachusetts
Ricky Sun, Bain Capital Life Sciences
Lavina Talukdar, Moderna
Lisa Tittemore, Sunstein LLP

2022 Museum of Science Board of Trustees Appointees:

Lauren Baker

Lauren Baker currently serves as the First Lady of the Commonwealth of Massachusetts alongside her husband, Governor Charlie Baker. As First Lady, Lauren works to improve the lives of the children of Massachusetts, focusing in particular on the children served by our Department of Children and Families through her work with the Wonderfund, a private, nonprofit that she helped launch. Lauren actively serves as a board member for Upstream, The Wonderfund and the Phoenix Charter Academy Foundation.
Priyanka Bobbili

Priyanka Bobbili, epidemiologist, and manager at the Analysis Group Inc. specializes in the analysis of large and complex real-world datasets to address healthcare questions. She has wide-ranging experience in epidemiology and outcomes research, including studies on causal methods, drug adherence and comparative-effectiveness, and through these projects has worked on multiple therapeutic areas such as oncology, cardiovascular disease, respiratory

disease, immunology and neurology.
Abraham Ceesay

Abraham Ceesay, president of Cerevel has nearly two decades of experience in leading biopharmaceutical companies and commercializing innovative therapeutic products. Prior to Cerevel, he served as chief executive officer at Tiburio Therapeutics, where he built a fully integrated company that led to the investigational new drug application enablement for a rare neuroendocrine tumor. Prior to Tiburio, he was the chief operating officer at scPharmaceuticals, where he developed and led all operations and commercial aspects of the organization. Abraham serves as chair of the Board of Directors for Life Science Cares.
Dr. Rana el Kaliouby

Dr. Rana el Kaliouby, deputy CEO at Smart Eye and co-founder of MIT startup Affectiva, is a scientist, entrepreneur, investor and AI thought leader on a mission to humanize technology before it dehumanizes us. Rana is also a General Partner at AI Operators Fund, an early-stage AI-focused venture fund and an executive fellow at the Harvard Business School, where she teaches about AI and startups. She is a World Economic Forum Young Global Leader. A passionate advocate for AI ethics and diversity in AI, Rana has been recognized on Fortune’s 40 Under 40 list, Forbes' Top 50 Women in Tech and Newsweek's Greatest Disruptors list. She speaks frequently on the application of AI in automotive, health and robotics.
Gregory Janey

Gregory Janey, president at CEO of Janey Construction Management and Consulting Inc., has been actively working for over 35 years overseeing a variety of complex construction and institutional programs. He uses his education and deep professional industry experience to provide opportunities for residents in and around the neighborhoods of where he grew up in Roxbury, Massachusetts. Greg continues to invest and advocate for the development of underserved Boston neighborhoods by providing scholarships for black Boston Public School students entering STEM education.
Andrea Kaneb

Andrea Kaneb, founder of Gathering Sound, is a tech advisor, advocate, and creator of educational resources for hearing assistive technologies and strategies. She is a presenter of Bluetooth audio, accessibility apps and the science behind challenges to hear in noise. Andrea participates in non-profit sectors promoting women in STEM, patient-centered care, accessibility in public venues and establishing a database for genetic hearing loss.
Dr. Sekar Kathiresan

Dr. Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, is a cardiologist and scientist who has focused his career on understanding the inherited basis for heart and attack and leveraging those insights to improve the care of cardiovascular disease. Based on his groundbreaking discoveries in human genetic mutations that confer resistance to cardiovascular disease, he co-founded Verve Therapeutics with a vision to create a pipeline of single-course, gene editing therapies focused on addressing the root causes of this highly prevalent and life-threatening disease.
Debbie Millin

Debbie Millin, CEO of UpperLevel Solutions, specializes in scaling rapid-growth companies. Her experience in building proprietary technology and product innovation created a new multi-billion-dollar category defining employment solutions of the future. Debbie is also a founding member and serves as an advisor to Globalization Partners, where she previously served as Chief Operating Officer. She frequently speaks on topics including entrepreneurship, rapid-growth companies, the future of work and women’s leadership.
Pallavi Verma

Pallavi Verma leads the Boston Office and is the North America Quality and Risk Lead for Accenture. She is responsible for working with clients and client teams to solve business problems and innovate by driving quality programs across all businesses and industries. Pallavi serves on the board of the Greater Boston Chamber of Commerce, Rush University Medical Center and the WE CAN organization.